Skye Bioscience, Inc. Proceeds from Lines of Credit
Skye Bioscience, Inc. (SKYE) reported Proceeds from Lines of Credit of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2022-03-28
- Skye Bioscience, Inc. proceeds from lines of credit for the quarter ending 2021-12-31 was $0.00.
- Skye Bioscience, Inc. proceeds from lines of credit for the quarter ending 2021-09-30 was $0.00.
- Skye Bioscience, Inc. proceeds from lines of credit for the quarter ending 2020-12-31 was $0.00.
- Skye Bioscience, Inc. proceeds from lines of credit for the quarter ending 2020-09-30 was $0.00.
- Skye Bioscience, Inc. proceeds from lines of credit for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Skye Bioscience, Inc. proceeds from lines of credit for fiscal 2020 was $450.00K.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $0.00 derived: sum of 2 quarters · filed 2022-03-28 | $0.00 10-K · filed 2022-03-28 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-06 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $0.00 derived: sum of 2 quarters · filed 2022-03-28 | $450.00K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $450.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $450.00K 10-Q · filed 2021-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |